Prime Medicine Inc (NASDAQ: PRME) kicked off on Friday, up 0.70% from the previous trading day, before settling in for the closing price of $2.87. Over the past 52 weeks, PRME has traded in a range of $2.56-$9.77.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -25.00% over the past five years. While this was happening, its average annual earnings per share was recorded 26.60%. With a float of $50.89 million, this company’s outstanding shares have now reached $131.16 million.
Let’s look at the performance matrix of the company that is accounted for 234 employees. In terms of profitability, gross margin is 98.47%, operating margin of -586.63%, and the pretax margin is -568.39%.
Prime Medicine Inc (PRME) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Prime Medicine Inc is 61.20%, while institutional ownership is 36.15%. The most recent insider transaction that took place on Feb 15 ’24, was worth 20,000,000. In this transaction Director of this company bought 3,200,000 shares at a rate of $6.25, taking the stock ownership to the 3,200,000 shares. Before that another transaction happened on Feb 15 ’24, when Company’s 10% Owner bought 3,200,000 for $6.25, making the entire transaction worth $20,000,000. This insider now owns 3,200,000 shares in total.
Prime Medicine Inc (PRME) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.60% per share during the next fiscal year.
Prime Medicine Inc (NASDAQ: PRME) Trading Performance Indicators
Take a look at Prime Medicine Inc’s (PRME) current performance indicators. Last quarter, stock had a quick ratio of 6.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 473.81.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.01, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.22 in one year’s time.
Technical Analysis of Prime Medicine Inc (PRME)
Prime Medicine Inc (NASDAQ: PRME) saw its 5-day average volume 0.67 million, a negative change from its year-to-date volume of 0.82 million. As of the previous 9 days, the stock’s Stochastic %D was 25.35%. Additionally, its Average True Range was 0.23.
During the past 100 days, Prime Medicine Inc’s (PRME) raw stochastic average was set at 13.41%, which indicates a significant decrease from 27.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.39% in the past 14 days, which was lower than the 80.63% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.22, while its 200-day Moving Average is $4.61. Nevertheless, the first resistance level for the watch stands at $2.97 in the near term. At $3.05, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.10. If the price goes on to break the first support level at $2.84, it is likely to go to the next support level at $2.79. The third support level lies at $2.71 if the price breaches the second support level.
Prime Medicine Inc (NASDAQ: PRME) Key Stats
The company with the Market Capitalisation of 379.05 million has total of 131,161K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -198,130 K annual income. Company’s last quarter sales were recorded 210 K and last quarter income was -52,520 K.
